Wegovy 0.25mg is the starting dose of a prescription GLP-1 medication designed to help adults and kids aged 12+ with obesity or overweight conditions manage weight effectively.

What Is Wegovy 0.25mg?

This once-weekly injection contains semaglutide, mimicking a natural hormone to curb appetite and slow digestion for better portion control.
It’s the lowest dose in a step-up program, prescribed alongside diet and exercise to kickstart safe weight loss.
Clinical data shows it reduces hunger signals to the brain, helping users feel fuller longer.​

Key Benefits of Wegovy 0.25mg

People starting Wegovy 0.25 mg often notice appetite suppression within weeks, setting the stage for gradual dose increases up to 2.4 mg.​
When combined with lifestyle changes, it supports sustained weight loss and lowers risks for heart disease or stroke in eligible patients.​
Early use minimizes side effects while building tolerance for higher doses that deliver stronger results.​

Common Side Effects of Wegovy 0.25mg

Nausea, diarrhea, vomiting, and constipation top the list, usually mild and fading as your body adjusts.
Other effects include headache, fatigue, abdominal pain, and dizziness—most hit 5%+ of users but rarely lead to stopping treatment.​
Serious risks like gallbladder issues, pancreatitis, or thyroid concerns are rare; monitor with your doctor.

How to Use It

Inject subcutaneously in the belly, thigh, or upper arm weekly, any time of day, with or without food.​
Start at 0.25 mg for 4 weeks; don’t increase until cleared by your provider.
Store pens in the fridge; let them warm to room temp before use for comfort.​

Get Started Today

Ready for real results? Consult your doctor to see if Wegovy 0.25 mg fits your goals—many telehealth services offer fast prescriptions and delivery.
Pair it with a calorie-reduced diet and activity for best outcomes; track progress weekly.